Concarlo is a women-founded and run company that is working to revolutionize the metastatic breast cancer field. The company is developing a new approach to inhibition of CDK4 that limits the development of resistance, which is common with current therapies.
Active Portfolio Company
https://concarlo.com/
Location: United States, New York
Employees: 1-10
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
| 25.06.2021 | Cavendish ... | cavendishf... |
| - | FirstXFoun... | firstxfoun... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 05.04.2024 | Concarlo Therapeutics Presents Novel Therapeutic Approach fo... | BROOKLYN, NY, UNITED STATES, April 5, 2024 /EINPresswire.com/ -- Concarlo Therapeutics ("Concar... | einpresswi... |
| 30.05.2023 | The academic to founder pipeline with Dr. Stacy Blain from C... | Welcome back to Found, where we get the stories behind the startups. This week, Becca and Dom are jo... | techcrunch... |